Beyond Type 1 Funding Model


Organization Note: This page is up to date through Q2’2020, and the organization will update this page quarterly. Questions can be directed to


What We Do: Beyond Type 1 is a nonprofit organization changing what it means to live with diabetes. Through platforms, programs, resources, and grants, Beyond Type 1 is uniting the global diabetes community and providing solutions to improve lives today. Founded in 2015 with a focus on education, advocacy and the path to a cure for Type 1 diabetes, Beyond Type 1 has grown to also include programs for those with Type 2 diabetes. A new model of philanthropy, Beyond Type 1 aims to change what it means to live with chronic illness.

Our Impact: Beyond Type 1 serves tens of thousands of people impacted by diabetes around the globe every day, and serves millions of people every month. The platforms represent the largest digital footprint of any diabetes organization in the world. Beyond Type 1 strives to create programs that offer solutions to improve the lives of those impacted by diabetes, while also building global reach and filling gaps in the diabetes space.

Community Donations: 100% of donations made by the community directly fund Beyond Type 1’s portfolio of platforms, programs and grants, making a direct and immediate impact in the lives of people living with diabetes.

Sponsorship Framework: In addition to the support of individual donors, Beyond Type 1 partners with corporations and organizations to support specific programs, educational content initiatives, and platforms through advertising. Corporate support is disclosed on materials related to each partnership, and is also available in aggregate on this page. Beyond Type 1 engages in corporate partnerships on a case-by-case basis, with input from the Board of Directors, Senior Staff, and various stakeholders internally and externally. The goal of partnerships is to further the organization’s mission and drive expanded impact.

Pharmaceutical Relationships: Beyond Type 1 partners with pharmaceutical companies, including insulin manufacturers, when the organization finds that doing so furthers mission and impact. Beyond Type 1 believes that high quality, modern insulin must be available to people with diabetes regardless of employment or insurance status, across all demographics, without barriers and at an affordable and predictable price point. The organization’s position is that these partnerships do not eliminate the ability to put pressure on these same companies related to insulin affordability and access, and such partnerships can create unique opportunities to drive change. Beyond Type 1 has published extensively on insulin affordability, and will continue to expand its role in insulin advocacy.

Volunteers + Pro Bono Services: The Beyond Type 1 staff is small, and relies heavily on volunteers . These volunteers include the Board of Directors, the Leadership Council, and thousands in the community who offer their support. Moreover, Beyond Type 1 is grateful to have robust pro bono services offered by Lowenstein Sandler LLP (Legal), by 9thWonder (Media Consulting), and by Diabetes Daily + Google Grants (Ads).


In addition to the generosity of tens of thousands of individual donors each year, Beyond Type 1 receives cash and in-kind contributions to sponsor programs, create educational content, and advertise on its platforms. Below is a list of all entities from whom Beyond Type 1 has received over $5,000 in cash funding over the previous 4 quarters combined, excluding individuals, individual/family donor advised funds, individual matching funds, and yet-to-be announced projects. Below the list you can find information explaining the projects that these partners’ funding supports.

$50,000+ combined over the last 4 quarters:

Abbott Diabetes Care
Association of Diabetes Care and Education Specialists (ADCES)
Helmsley Charitable Trust*

Eli Lilly & Co
One Drop

$5,000+ combined over the last 4 quarters:

American Diabetes Association (ADA)
Companion Medical
DreaMed Diabetes LTD
Koia / Raw Natures
Lexicon Pharmaceuticals
Real Good Foods
Shop the Drop (Former Org Subsidiary)

The Otis Booth Foundation
University of Utah
Xeris Pharmaceuticals

*The Helmsley Charitable Trust issued a grant for the Beyond Type 1 DKA Campaign in 2018, with the grant running through 2020. Beyond Type 1 is grateful for their continued support.

Financial support from the above partners is tied to programs, educational content, or platform-based advertising. Below is more information related to all sponsor/partner integrations over $5,000 from the last 4 quarters.


Diabetes Scholars
In addition to scholarships provided by individual and family donors, 2020 Scholarships for students with Type 1 diabetes included those made possible by Dexcom, JDRF, Lilly Diabetes, Medtronic, One Drop, and a number of individual donors. 100% of scholarship funds donated are awarded to recipients, with Beyond Type 1 absorbing all operational costs associated with the program. Learn more here.

DKA Campaign (Warning Signs)
The DKA Campaign, which raises awareness for the warning signs of Type 1 diabetes with a goal of preventing death due to misdiagnosis, is supported by The Helmsley Charitable Trust. More information here.

SafeSittings Diabetes Babysitting Service, to aid members of the community in finding babysitters who understand management of diabetes, is made possible with support from Insulet, makers of Omnipod. Learn more here.

Slipstreams (with Connected In Motion)
Slipstream events, created in partnership with Connected In Motion, are supported by Dexcom, Medtronic, Omnipod, Tandem Diabetes Care and One Drop. Their support makes programming weekend-long events for adults with Type 1 diabetes possible. 2020 events have largely transitioned to virtual programming in light of COVID-19. More information here.

Snail Mail Club
The Snail Mail Club, connecting members of the Type 1 diabetes community of all ages with pen pals, is made possible with support from Presenting Sponsor Abbott Diabetes Care. More information here. /
The and platforms, providing community support and conversation in English and Spanish for those impacted by T1D and T2D, are made possible with support from One Drop. Additional research on these platforms is made possible with support from the University of Utah.


Beyond Type 1 partners to fund the creation of educational resources. Beyond Type 1 retains full editorial control of all content published on organization platforms, and news coverage is managed independently from content partnerships. The below list provides more details related to content initiatives from the last 12 months from the above funding sources; content from current and past partnerships also include disclosures in line on content pieces.

Beyond Type 2
Beyond Type 2 is made possible by the support of a coalition of Partners dedicated to making life better for those impacted by Type 2 diabetes: Abbott (FreeStyle Libre 14 Day System), The Association of Diabetes Care and Education Specialists (ADCES), Lilly Diabetes (Baqsimi), Insulet Corporation (Omnipod), and Roche Diabetes Care (Accu-Chek). Learn more here.

Artificial Intelligence (AI) and Diabetes Care
Content about the future of artificial intelligence as it relates to diabetes care, and information about the creation of algorithms for future Hybrid Closed Loop systems was made possible with support from DreaMed Diabetes.

Armed for Diabetes Awareness Campaign
A website aimed to educate and raise awareness of Continuous Glucose Monitoring (CGM) technology among veterans with diabetes who access care via the VA was made in partnership with Abbott.

CGM Awareness Content
Beyond Type 1 has published a large library of content on technology and diabetes, Select pieces of educational content about the benefits of Continuous Glucose Monitoring (CGM) for people with diabetes was made possible with support from Abbott and Dexcom.

Connected Diabetes Management
Development of new content, and updates to existing content about management of diabetes via digital apps + virtual diabetes coaching was made possible with support from One Drop.

Device Access Awareness
A set of resources sharing information about how to access the latest diabetes technology were made possible with support from Insulet.

DKA in Management Awareness
Updated resources on how to recognize and treat DKA while managing Type 1 diabetes were made possible with a grant from Lexicon Pharmaceuticals.

European Language Expansion
The creation of Beyond Type 1 websites in Dutch, French, German, Italian and Swedish, was made possible with support from Dexcom and Insulet.

Hybrid Closed Loop Pump Awareness
Resources on the latest advancements and approvals of Automated Insulin Delivery (AID) systems, and the benefits of Hybrid Closed Loop therapy, were made possible with support from Tandem Diabetes Care.

Imagine Spotlights
Beyond Type 1 and the ADA partnered to create a speaker series featuring notable voices in the diabetes community as part of the ADA’s Imagine Camps program.

Knowledge Drop Expert Interview Series
Live conversations throughout National Diabetes Awareness Month 2019 — with diabetes experts covering key areas impacting everyone with Type 1 diabetes — were made possible with support from Lexicon Pharmaceuticals.

Next-Gen Glucagon Content
A set of resources about liquid-stable glucagon, severe hypoglycemia, and next-gen glucagon delivery devices were made possible with support from Xeris Pharmaceuticals.

September Summits
Live, in-depth conversations with community members and healthcare providers about topics facing the diabetes community, produced by the JDRF-Beyond Type 1 Alliance and made possible with support from One Drop, Roche Diabetes Care and Xeris Pharmaceuticals.

Severe Hypoglycemia Initiative
The Severe Hypoglycemia Initiative raises awareness about the seriousness and treatment options for very low blood sugar for people with both Type 1 and Type 2 diabetes. The Severe Hypoglycemia Initiative was made possible with support from Lilly Diabetes.

Sleep and Diabetes Resources
Resources on sleep and diabetes, which debuted during National Sleep Week in March 2020 were made possible with support from Medtronic.

SmartPen Content
Creation of resources regarding SmartPen technology was made possible with support from Companion Medical.


Beyond Type 1 engages in advertising relationships with partners to support platforms; these ad units appear in the footer of websites, alongside email campaigns, or in disclosed advertising content. Beyond Type 1 does not engage with 3rd party advertising networks, and does not provide individual user information to advertisers without explicit user consent.

The below list includes current advertisers:

Abbott Diabetes Care
Companion Medical

One Drop
Real Good Foods
Tandem Diabetes Care
Steady Health


Below includes partnerships listed in the Funding Source Summary that are not referenced in the above categories:

  • JDRF: The JDRF – Beyond Type 1 Alliance
  • Otis Booth Foundation: Continued operational funding as a Founding Friend
  • Shop The Drop: Proceeds from the Beyond Type 1 shop subsidiary sales
  • WeAre8: Sponsor for 2019 Partners Event during ADA Scientific Sessions
  • Withings: Sponsor for Beyond Type Run, the 2019 NYC Marathon Team (which was supported by a coalition of partners including Dexcom, Tandem, T1DExchange, Tidepool, Alala, Rhone, MedAngel, One Drop and Withings at various levels over 12 months ago).


We are forever grateful to our Founding Friends whose generous gifts supported operations from 2015-2017, allowing Beyond Type 1 to build an organization supporting millions every month.

Loren + Mike Gordon
Amy + John Griffin
Cathie + Pitch Johnson
Gisel + Omid Kordestani
Kate + Gregg Lemkau

Leslie + William McMorrow
Jennifer + John Nordstrom
Otis Booth Foundation
Regina + John Scully


In addition to the active paid partnerships listed in the Funding Sources section of this page, Beyond Type 1 collaborates with many entities where the organization does not receive funding as part of the collaboration. Below lists current partners that are not sponsors of Beyond Type 1. We often work with our corporate sponsors listed above in both paid and unpaid capacities as well. If you do active work with Beyond Type 1 and are not listed below, please email

Alliance to Modernize Prescribing Information (AMPI)
American Association of Clinical Endocrinologists (AACE)
Anedia Diabetes
APDP – Portugal
Arogya World
Ascensia Diabetes Care
Asociación Chilena de Enfermeros Educadores en Diabetes
Asociacion Diabetes Madrid
Asociación DiaVida
Asociación Mexicana de Diabetes
Asociación para la Diabetes de Tenerife (ADT)
Asociación Valenciana de Diabetes
Australian Diabetes Educators Association
Australian Diabetes Society
Australian Paediatric Society
Blue Circle Diabetes Foundation
Brazilian Diabetes Society
Bulgarian Diabetes Association
Bulgarian Society of Endocrinology
California Institute for Regenerative Medicine (CIRM)
Canadian Pediatric Endocrine Group
Canadian Pediatric Society
Canal Diabetes
Carb DM
Cecelia Health
Certification Board for Diabetes Care and Education (CBDCE, formerly NCBDE)
Children With Diabetes
Close Concerns
College Diabetes Network (CDN)
Connected In Motion
Cyprus Diabetic Association
DANII Foundation
Diabetes Action Canada
Diabetes Australia
Diabetes Canada
Diabetes Connections
Diabetes Daily
Diabetes Disaster Relief Coalition (DDRC)
Diabetes Education & Camping Association (DECA)
Diabetes Experience Day
Diabetes Fighters Trust
Diabetes Hope Foundation
Diabetes NZ
Diabetes Online Community
Diabetes Patient Advocacy Coalition (DPAC)
Diabetes Patient Association – Canary Islands
Diabetes Policy Collaborative (DPC)
Diabetes What to Know
Diabetes Quebec
Diabetes Research Institute Foundation (DRIF)
Diabetes Sports Project (DSP)
Diabetes Youth Families
DiabetesDE (Germany)
DiabetesMine / Healthline
DiaTribe Foundation
DIYA (India)
Enable BioSciences
Endocrine Society (ENDO)
Federación de Asociaciones de Diabetes de Canarias (FAdiCAN)
Fondazione Italiana Diabete

FRED – Fondation Ressources Pour Les Engantes Diabétiques
Frio UK
Fundación Diabetes Juvenil de Chile
Gales Creek Camp
Global Heart Health
Guerreros Azules
Harvard Medical School
Hellenic Diabetes Federation
Hospital Sant Joan de Déu
I Challenge Diabetes
Insulin For Life
International Diabetes Federation (IDF)
International Diabetes Federation – Europe
International Society for Pediatric and Adolescent Diabetes (ISPAD)
Jaeb Center for Health Research
JDRF Australia
JDRF Canada
JDRF Israel
JDRF Netherlands
JDRF United Kingdom
Life for a Child
LifeScan Diabetes Institute
Maggiore Hospital
Malawi Diabetes Foundation
Mammoth Creameries
Marjorie’s Fund
Mexican Diabetes Federation
Mil Familias
Milken Institute
National Association of School Nurses (NASN)
NCD Alliance
National Diabetes Volunteer Leadership Council (NDVLC)
PAANDA Diabetes
Partnership to Improve Patient Care (PIPC)
Project ECHO
Purchase District Health Department
Riding On Insulin (ROI)
Romanian Diabetes Federation
Samatvan Centre
Sansum Diabetes Research Institute
Second Hope for Diabetes
Sirma Medical Systems
Smarter Health Care Coalition / Healthsperien
Social Diabetes
Sociedad Española de Diabetes
Sonia Nabeta Foundation
Stanford Diabetes Research Center
T1D Exchange
T1D Learning Centre
Team Novo Nordisk
The Human Trial
UNC Chapel Hill
University of Florida Diabetes Institute
We Are Diabetes
Xeris Pharmaceuticals


The Beyond Type 1 Board of Directors abide by a Conflict of Interest policy that requires disclosure and potential recusal from decision-making should the organization partner with an entity that a Director has a financial relationship with. This policy is available HERE.

Beyond Type 1 is currently preparing its 2019 tax filings, and plans to make public versions of that filings and prior years’ filings available following the 2019 submission.

If you have questions about the Beyond Type 1 funding model, please email: